Kinaxis Inc. (TSE:KXS – Free Report) – Stifel Canada upped their Q3 2024 earnings per share (EPS) estimates for shares of Kinaxis in a research note issued to investors on Wednesday, October 23rd. Stifel Canada analyst S. Sukumar now forecasts that the company will earn $0.43 per share for the quarter, up from their prior forecast of $0.41. The consensus estimate for Kinaxis’ current full-year earnings is $4.25 per share. Stifel Canada also issued estimates for Kinaxis’ Q4 2024 earnings at $0.54 EPS and FY2024 earnings at $1.78 EPS.
Several other analysts have also recently issued reports on the stock. ATB Capital lowered their price objective on shares of Kinaxis from C$215.00 to C$205.00 and set an “outperform” rating for the company in a research note on Friday, August 2nd. Scotiabank dropped their target price on Kinaxis from C$200.00 to C$190.00 in a research report on Thursday, August 29th. Stifel Nicolaus cut their price target on shares of Kinaxis from C$210.00 to C$195.00 and set a “buy” rating on the stock in a report on Friday, August 2nd. Finally, TD Securities reduced their target price on Kinaxis from C$200.00 to C$195.00 in a report on Friday, August 2nd. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of C$192.11.
Kinaxis Stock Performance
Shares of KXS opened at C$157.05 on Friday. The company has a current ratio of 1.90, a quick ratio of 2.29 and a debt-to-equity ratio of 12.40. The company has a 50-day moving average of C$154.74 and a two-hundred day moving average of C$154.08. Kinaxis has a 12-month low of C$129.13 and a 12-month high of C$172.83. The stock has a market cap of C$4.44 billion, a P/E ratio of 157.05, a PEG ratio of 3.60 and a beta of 0.78.
Kinaxis (TSE:KXS – Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported C$0.42 earnings per share for the quarter, beating analysts’ consensus estimates of C$0.27 by C$0.15. The company had revenue of C$161.83 million for the quarter, compared to analyst estimates of C$160.55 million. Kinaxis had a return on equity of 4.87% and a net margin of 4.59%.
Insiders Place Their Bets
In other news, Senior Officer Megan Paterson sold 3,172 shares of Kinaxis stock in a transaction on Friday, September 13th. The stock was sold at an average price of C$156.28, for a total transaction of C$495,720.16. Following the transaction, the insider now directly owns 121 shares in the company, valued at approximately C$18,909.88. This trade represents a 0.00 % decrease in their position. In other Kinaxis news, Senior Officer Megan Paterson sold 3,172 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of C$156.28, for a total value of C$495,720.16. Following the completion of the sale, the insider now directly owns 121 shares of the company’s stock, valued at approximately C$18,909.88. This represents a 0.00 % decrease in their position. Also, Senior Officer Andrew William Robert Bell sold 701 shares of Kinaxis stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of C$149.56, for a total transaction of C$104,841.70. Following the completion of the transaction, the insider now directly owns 831 shares in the company, valued at C$124,284.53. This represents a 0.00 % decrease in their position. Insiders sold 8,265 shares of company stock worth $1,268,146 over the last ninety days. Company insiders own 1.20% of the company’s stock.
Kinaxis Company Profile
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
Further Reading
- Five stocks we like better than Kinaxis
- How to Calculate Return on Investment (ROI)
- Texas Roadhouse Stock Steering for New Highs This Year
- Transportation Stocks Investing
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.